Copyright
©The Author(s) 2024.
World J Clin Cases. Aug 6, 2024; 12(22): 4999-5007
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4999
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4999
Study group (n = 40) | Control group (n = 40) | χ2/t | P value | |
Age (year) | 56.182 ± 5.174 | 56.744 ± 4.956 | 0.496 | 0.621 |
Sex (number of people) | 0.051 | 0.822 | ||
Male | 23 (57.5) | 22 (55.0) | ||
Female | 17 (42.5) | 18 (45.0) | ||
Pathological examination (number of people) | 0.212 | 0.976 | ||
Craniocerebral trauma | 13 (32.5) | 12 (30.0) | ||
Cerebrovascular disease | 10 (25.0) | 11 (27.5) | ||
Brain tumor | 11 (27.5) | 10 (25.0) | ||
Others | 6 (15.0) | 7 (17.5) | ||
Pathological grading (number of people) | 0.347 | 0.841 | ||
Level I | 6 (15.0) | 8 (20.0) | ||
Level II | 16 (40) | 15 (37.5) | ||
Level III | 18 (45.0) | 17 (42.5) | ||
Surgical method (number of people) | 0.120 | 0.942 | ||
Emergency neurosurgical surgery | 13 (32.5) | 12 (30.0) | ||
Vascular neurosurgery | 10 (25.0) | 11 (27.5) | ||
Tumor neurosurgery surgery | 11 (27.5) | 10 (25.0) | ||
Average duration of illness (year) | 3.212 ± 0.028 | 3.214 ± 0.016 | 0.392 | 0.696 |
Hospitalization days (day) | 120.212 ± 0.321 | 120.221 ± 0.241 | 0.142 | 0.888 |
Follow up time (month) | 8.654 ± 0.352 | 8.587 ± 0.314 | 0.898 | 0.372 |
Adjuvant therapy (number of people) | 20 (50.0) | 18 (45.0) | 0.201 | 0.654 |
Study group (n = 40) | Control group (n = 40) | χ2 | P value | |
Adverse event occurrence rate | 2 (5.00) | 8 (20.0) | 4.114 | 0.043 |
Falling bed | 0 (0.00) | 3 (7.50) | ||
Fall | 2 (5.00) | 5 (12.5) | ||
Medication errors | 0 (0.00) | 0 (0.00) | ||
Incidence rate of complications | 2 (5.00) | 9 (27.50) | 4.877 | 0.027 |
Postoperative infection | 1 (2.50) | 3 (7.50) | ||
Gastrointestinal bleeding | 1 (2.50) | 1 (2.50) | ||
Central hyperthermia | 0 (0.00) | 5 (12.50) |
Factor variables | Adverse event occurrence rate | Incidence rate of complications | |||
χ2 | P value | χ2 | P value | ||
Age | Study group | 2.347 | 0.128 | 2.357 | 0.124 |
Control group | 2.312 | 0.115 | 2.416 | 0.123 | |
Sex | Study group | 1.879 | 0.086 | 1.991 | 0.115 |
Control group | 1.892 | 0.088 | 2.046 | 0.114 | |
Pathological examination | Craniocerebral trauma | 3.816 | 0.567 | 5.552 | 0.689 |
Cerebrovascular disease | 4.881 | 0.621 | 8.887 | 0.992 | |
Brain tumor | 6.287 | 0.847 | 6.884 | 0.846 | |
Pathological grading | Level I | 4.352 | 0.568 | 5.884 | 0.703 |
Level II | 3.221 | 0.504 | 3.846 | 0.576 | |
Level III | 4.968 | 0.322 | 1.032 | 0.052 | |
Surgical method | Emergency neurosurgical surgery | 12.117 | 0.031 | 15.874 | 0.868 |
Vascular neurosurgery | 5.869 | 0.698 | 4.992 | 0.017 | |
Tumor neurosurgery surgery | 17.425 | 0.039 | 13.448 | 0.984 | |
Nursing methods | Routine care | 9.554 | 0.037 | 8.772 | 0.021 |
High quality nursing services | 7.687 | 0.787 | 8.996 | 0.986 | |
High quality health education | 6.886 | 0.846 | 7.369 | 0.916 | |
High quality regional services | 11.125 | 0.884 | 16.845 | 0.789 | |
High quality psychological services | 8.467 | 0.656 | 6.997 | 0.693 | |
Adjuvant therapy | Yes | 2.312 | 0.042 | 3.568 | 0.521 |
No | 7.221 | 0.579 | 6.741 | 0.075 |
- Citation: Li XR, Luo QL. Effects of high-quality neurosurgical nursing care on improving clinical nursing quality. World J Clin Cases 2024; 12(22): 4999-5007
- URL: https://www.wjgnet.com/2307-8960/full/v12/i22/4999.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i22.4999